Monterio et al. applied ML techniques (RF, Xgbosst, SVM and Decision tree) to predict the functional outcome of ischemic stroke patients (n = 425) treated with Recombinant Tissue Plasminogen Activator (rtPA) 3 months after the initial stroke. This evidence concerns the gene PLAT and stroke disorder.